| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Tolerantia, LLC | 36% | -3.9% | $93,004,165 | -$3,326,877 | 106,901,339 | -3.5% | Tolerantia, LLC | 03 Jun 2025 |
| MORGAN STANLEY | 4.4% | -42% | $3,370,156 | -$2,564,610 | 5,712,128 | -43% | Morgan Stanley | 30 Jun 2025 |
| BlackRock, Inc. | 1.4% | $1,182,283 | 1,764,602 | BlackRock, Inc. | 30 Jun 2025 |
As of 31 Dec 2025, 1 institutional investors reported holding 1,000,000 shares of PROKIDNEY CORP. - Ordinary Shares (PROK). This represents 0.77% of the company’s total 129,821,091 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 1,000,000 | $2,240,000 | -$2,308 | $2.24 | 1 |
| 2025 Q3 | 1,000,917 | $2,422,308 | -$19,991,585 | $2.42 | 4 |
| 2025 Q2 | 34,704,784 | $20,548,205 | -$8,230,826 | $0.59 | 50 |
| 2025 Q1 | 47,997,221 | $42,032,793 | -$2,665,006 | $0.88 | 68 |
| 2024 Q4 | 50,919,833 | $86,053,287 | +$2,729,891 | $1.69 | 72 |
| 2024 Q3 | 49,144,737 | $94,328,129 | +$11,886,322 | $1.92 | 69 |
| 2024 Q2 | 40,154,003 | $98,780,645 | +$33,020,412 | $2.46 | 63 |
| 2024 Q1 | 26,784,444 | $43,927,164 | -$4,143,589 | $1.64 | 52 |
| 2023 Q4 | 29,378,261 | $52,277,921 | -$53,744,159 | $1.78 | 61 |
| 2023 Q3 | 40,416,757 | $185,108,424 | +$2,228,153 | $4.58 | 64 |
| 2023 Q2 | 39,818,774 | $445,584,614 | +$58,753,645 | $11.19 | 56 |
| 2023 Q1 | 34,565,347 | $391,195,593 | +$35,473,985 | $11.32 | 35 |
| 2022 Q4 | 31,432,933 | $215,647,663 | +$14,576,098 | $6.86 | 27 |
| 2022 Q3 | 16,024,777 | $144,383,000 | +$137,048,999 | $9.01 | 16 |
| 2022 Q2 | 736,968 | $7,334,000 | +$7,334,000 | $9.95 | 1 |